Skip to main content

Funding Calls Database « All Calls


Funder(s): Anticancer Fund, Solving Kids’ Cancer, The Evan Foundation, Kindred Foundation, Zoé4life,

One RFA is a Research Funding Award launched by the ACTION Consortium, an international collaboration that has the ambition to find innovative approaches to tackle neuroblastoma.

The call is focused on refractory and relapsed neuroblastoma, calling for innovative approaches to accelerating clinical trials, and evaluation of novel therapies. By pooling our resources to form the ACTION Consortium, this award will be one of the largest seen in the neuroblastoma field, standing at $2 million.

Founded by five non-profit organisations, Anticancer Fund (Belgium), The Evan Foundation (United States), Kindred Foundation (Canada), Solving Kids’ Cancer (United Kingdom) and Zoé4Life (Switzerland), the ACTION Consortium is a collective force committed to Advancing Clinical Trial Implementation and Optimisation in Neuroblastoma.

Timeline & Milestones

Call Open

September 26, 2022

Deadline First stage (LOI / pre-proposal)

March 6, 2023

Deadline Full Application

August 14, 2023

Grant Decision – Final Decision – Awarding

November 1, 2023

Unfortunatly this funding call is not open for applications.